This corresponds to a study showing that IL10-protein is decreased during relapses [28], whereas data from a study on a mixed MS group and a non-inflammatory control group [29], reported increased IL10 mRNA expression in in CSF-cells from MS. Here, IL10 is linked to myeloid sarcoma.